Carotid Stents Used In NIH CREST Trial Could Receive HCFA Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
Stent-assisted carotid percutaneous angioplasty procedures (SACPTA) performed as part of the NIH-funded Carotid Revascularization Endarterectomy v. Stenting (CREST) trial could be reimbursed under Medicare provided preliminary data shows favorable outcomes.
You may also be interested in...
Bard R&D To Triple In Three Years Through Savings From Plant Consolidation
Consolidation of C.R. Bard manufacturing and non-manufacturing facilities over the next three years is expected to save the firm up to $70 mil. annually and allow the firm to roughly triple its R&D budget to about $150 mil. by 2004.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”